Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer - Concepedia

Concepedia

Publication | Open Access

Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer

DOI Full Paper Access

114

Citations

41

References

2017

Year

Kyojiro Kawakami, Yasunori Fujita, Yoko Matsuda, Tomio Arai, Kengo Horie, Koji Kameyama, Taku Kato, Koichi Masunaga, Yutaka Kasuya, Masashi Tanaka,

Abstract

Our results suggest that serum exosomal GGT activity could be a useful biomarker for PC.

References

	Year	Citations
Cancer statistics, 2014 Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou, CA A Cancer Journal for Clinicians Epidemiology Of CancerCancer RegistrationUnited StatesCancer Risk FactorsGynecology Oncology	2014	11.5K
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry, New England Journal of Medicine	2004	5.7K
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids Clotilde Théry, Sebastián Amigorena, Graça Raposo, Current Protocols in Cell Biology Biological FluidsCell CultureExtracellular MicrovesiclesCellular PhysiologyExosome Purification	2006	5.7K
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature Peter Y. Park, Teresa A. Goldin, John C. S. Chang, Case Reports in Oncology	2015	5.3K
Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Cancer Scott A. Tomlins, Daniel R. Rhodes, Sven Perner, Science Outlier Gene ExpressionEngineeringGeneticsMolecular BiologyRecurrent Fusion	2005	3.8K
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer Sónia A. Melo, Linda B. Luecke, Christoph Kahlert, Nature Tumor BiologyPancreatic CancerMedicineCancer Cell BiologyCancer Biology	2015	2.8K
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men William J. Catàlona, John P. Richie, Frederick R. Ahmann, The Journal of Urology	1994	1.4K
Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease William J. Catalona, Alan W. Partin, Kevin M. Slawin, JAMA	1998	1.2K
Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study Dominik Berthold, Gregory R. Pond, Freidele Soban, Journal of Clinical Oncology	2008	1.1K
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. George N. Thalmann, Ploutarchos Anezinis, Shi Chang, PubMed UrologyOncologyLncap ModelGenitourinary CancerMedicine	1994	739

Page 1